Antipsychotic dosing: still a work in progress

Am J Psychiatry. 2010 Jun;167(6):623-5. doi: 10.1176/appi.ajp.2010.10030302.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use
  • Aripiprazole
  • Benzodiazepines / pharmacology
  • Benzodiazepines / therapeutic use
  • Dibenzothiazepines / pharmacology
  • Dibenzothiazepines / therapeutic use
  • Drug Administration Schedule
  • Humans
  • Olanzapine
  • Piperazines / pharmacology
  • Piperazines / therapeutic use
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / metabolism
  • Psychotic Disorders / psychology
  • Quetiapine Fumarate
  • Quinolones / pharmacology
  • Quinolones / therapeutic use
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Dopamine D2 / metabolism
  • Severity of Illness Index

Substances

  • Antipsychotic Agents
  • Dibenzothiazepines
  • Piperazines
  • Quinolones
  • Receptors, Dopamine D2
  • Benzodiazepines
  • Quetiapine Fumarate
  • Aripiprazole
  • Olanzapine